BIT Capital’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$63.8K Sell
3,181
-16,205
-84% -$325K ﹤0.01% 72
2025
Q1
$382K Buy
+19,386
New +$382K 0.03% 58